Episode 435: An Overview of Hodgkin Lymphoma for Oncology Nurses
From The ONS Podcast · · 35 min
This plays from the publisher's own server. We do not host a copy.
Description
"The accumulation of these malignant and reactive cells, that's what causes the lymph nodes to get big. That's why they grow. And that's why the classic presentation is persistent, painless, enlarged lymph nodes. So when we think of the pathophysiology of Hodgkin lymphoma, there are really two processes contributing to the presentation: One is the physical effects of enlarging lymph nodes or the involved organs. The second is the systemic inflammatory response generated by it and its surrounding immune environment," ONS member Victoria Krogg, DNP, APRN-CNP, AOCNP®, nurse practitioner at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute in Columbus, OH, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about an overview of Hodgkin lymphoma for oncology nurses.
Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by October 2, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: Learners will report an increase in knowledge related to the pathophysiology and diagnosis of Hodgkin lymphoma.
Episode Notes - Complete this evaluation for free NCPD.
- ONS Podcast™ episodes: - Episode 339: A Lesson on Labs: How to Monitor and Educate Patients With Cancer
- Episode 256: Cancer Symptom Management Basics: Hematologic Complications
- Episode 208: How to Have Fertility Preservation Conversations With Your Patients
- Episode 184: Oncologic Emergencies 101: Tumor Lysis Syndrome
- ONS Voice articles: - Diabetes May Increase Hematologic Cancer Risk and Mortality
- Have Meaningful Conversations With Pediatric, Adolescent, and Young Adult Patients and Their Families
- Non-Hodgkin Lymphoma Symptoms, Diagnosis, Treatment, and Survivorship Recommendations
- Clinical Journal of Oncology Nursing articles: - Non-Hodgkin Lymphoma: Examining Mycosis Fungoides and Sézary Syndrome in the Context of Oncology Nursing
- The Unexpected Cancer Journey: Navigating Cancer as Adolescents and Young Adults
- Tumor Lysis Syndrome in Solid and Hematologic Malignancies: A Guide for Early Detection and Intervention
- ONS Huddle Cards: - Fertility Preservation
- Oncogenic Viruses
- Tumor Lysis Syndrome
- ONS Symptom Management Resource: Fatigue
- Hematology, Cellular Therapy, and Stem Cell Transplantation Learning Library
- Blood Cancer United: Hodgkin Lymphoma
- Lymphoma Research Foundation: Hodgkin Lymphoma
- National Comprehensive Cancer Network (https://www.nccn.org/)
To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/).
To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From This Episode "Hodgkin lymphoma can be diagnosed at virtually any age but is more common in younger patients as well as older adults. It kind of skips middle-aged people, but it occurs in our geriatric population as well. There are different prognostic implications depending on the group of patients that are diagnosed with Hodgkin lymphoma. As far as risk factors ... Hodgkin lymphoma is not considered a hereditary disease. There's not a specific gene we know of today that can be passed down to children and put them at risk. But if there is a first-degree relative affected by a lymphoma, we do find that noteworthy. We do consider it a risk factor. But that risk factor…